Abstract: The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.

Abstract: The present invention provides novel hepcidin analogues, and related methods of using these hepcidin analogues to treat or prevent a variety of diseases and disorders, including iron overload diseases such as hereditary hemochromatosis, iron-loading anemias, and other conditions and disorders described herein.

Abstract: The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Abstract: Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease, are disclosed.

Abstract: The present invention relates, inter alia, to certain hepcidin peptide analogs, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Abstract: The invention is directed to opioid agonist peptides and their use.

Abstract: The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Abstract: The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Abstract: The invention is directed to opioid agonist peptides and their use.

Abstract: The invention is directed to opioid agonist peptides and their use.

Abstract: The present invention provides hepcidin analogues with improved in vivo half-lives, and related pharmaceutical compositions and methods of use thereof.

Abstract: The present invention relates to a method to synthesize ammonia at moderate conditions. The present invention also relates to a new chemical reactor configuration to achieve ammonia synthesis at moderate pressures and temperatures, and methods to make membranes for use in ammonia synthesis.

Abstract: The present invention relates, inter alia, to certain hepcidin peptide analogs, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Abstract: The present invention provides novel hepcidin analogues, and related methods of using these hepcidin analogues to treat or prevent a variety of diseases and disorders, including iron overload diseases such as hereditary hemochromatosis, iron-loading anemias, and other conditions and disorders described herein.

Abstract: Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease are described.

Abstract: The present invention relates to a method to synthesize ammonia at moderate conditions. The present invention also relates to a new chemical reactor configuration to achieve ammonia synthesis at moderate pressures and temperatures, and methods to make membranes for use in ammonia synthesis.

Abstract: The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Abstract: The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease.

Abstract: A system and methods are provided for communication between entities that need to coordinate on scheduling events. Communication between schedulers, such as coaches, athletic administrators or organization administrators who may be in charge of a multiplicity of sports or activities at institutions, such as colleges or universities, who need to connect and communicate on a particular task. These tasks may include scheduling of events such as sports competitions or other events or activities in which there may be shared or common interests or a shared network of users, players or participants. Search by criteria to find matching potential opponents for scheduling events is also provided. Automatic schedule updates are maintained, typically in a logically centralized database, facilitated by a messaging system to facilitate ease of scheduling.

Abstract: A system and methods are provided for communication between entities that need to coordinate on scheduling events. Communication between schedulers, such as coaches, athletic administrators or organization administrators who may be in charge of a multiplicity of sports or activities at institutions, such as colleges or universities, who need to connect and communicate on a particular task. These tasks may include scheduling of events such as sports competitions or other events or activities in which there may be shared or common interests or a shared network of users, players or participants. Search by criteria to find matching potential opponents for scheduling events is also provided. Automatic schedule updates are maintained, typically in a logically centralized database, facilitated by a messaging system to facilitate ease of scheduling.